Tokyo, 101-0048,
Japan
Otsuka Pharmaceutical Technographics
Otsuka Pharmaceutical Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Otsuka Pharmaceutical and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 33226 Otsuka Pharmaceutical employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Otsuka Pharmaceutical has purchased the following applications: Kinjiro Time and Attendance for Time and Attendance in 2019, GlobalData Intelligence Center for Account Based Marketing in 2017, Kore.ai for Chatbots and Conversational AI in 2024 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Otsuka Pharmaceutical is running and its propensity to invest more and deepen its relationship with Kinjiro Co , GlobalData , Adobe Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Otsuka Pharmaceutical revenues, which have grown to $13.00 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Otsuka Pharmaceutical intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Otsuka Pharmaceutical Tech Stack and Enterprise Applications
Otsuka Pharmaceutical HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Kinjiro Co | Legacy | Kinjiro Time and Attendance | Time and Attendance | HCM | n/a | 2019 | 2019 |
In 2019 Otsuka Pharmaceutical implemented Kinjiro Time and Attendance to strengthen internal attendance controls and support telework era requirements. The Kinjiro Time and Attendance application was introduced by vendor Kinjiro Co and positioned within the Time and Attendance category as part of a broader update to in-house systems.
Implementation scope focused on attendance management capabilities that support distributed workstyles, with functionality described as ideal for telework. Configurations emphasized real time status capture through integrated communication channels, and mechanisms to record employee self reported activity, enabling managers to query what employees are doing now as part of working hours management.
The deployment was linked with the SMILE series which Otsuka provides as a core business system, and the Kinjiro integration was designed to operate alongside updates to personnel affairs and payroll systems. Operational coverage was internal to Otsuka Co., Ltd and involved collaboration with Otsuka Shokai, aligning attendance data flows with HR and payroll processes rather than replacing named third party platforms.
Governance and process changes accompanied the rollout, reflecting a company level push toward work style reform and a belief that a solid core system is necessary to support DX and flexible work. Employees reported that the introduction made it possible to integrate working hour management when around 60 percent of staff worked from home, and the program was perceived as a concrete effort by the company to change work practices.
|
Otsuka Pharmaceutical CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| GlobalData | Legacy | GlobalData Intelligence Center | Account Based Marketing | CRM | n/a | 2017 | 2018 |
In 2017, Otsuka Pharmaceutical deployed GlobalData Intelligence Center. The GlobalData Intelligence Center was adopted to support Account Based Marketing across Otsuka Pharmaceutical, aligning account-level intelligence with commercial planning for the life sciences business.
The implementation emphasized core Account Based Marketing capabilities, including account profiling, targeted account segmentation, contact enrichment, intent signal consumption, and campaign orchestration workflows consistent with ABM practices. Configuration work centered on creating account datasets and segment definitions that feed outbound account-specific engagement and demand generation processes.
Operational ownership resided with Otsuka commercial marketing and sales enablement teams, with the platform used to inform account prioritization and cross-functional outreach. The deployment was positioned as a source of consolidated account intelligence for marketing and sales, rather than as a point solution for a single team.
Otsuka Associate Director Atsuko Nakano provided a testimonial noting vendor support, saying You provide us with very generous support compared to other database vendors we are currently using, and When we need something, GlobalData responds immediately. Ongoing vendor responsiveness was highlighted as a key element of the platform governance and operational model.
|
|
|
|
|
Customer Experience | CRM |
|
2018 | 2018 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
Otsuka Pharmaceutical AI-Powered Application
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Kore.ai | Legacy | Kore.ai | Chatbots and Conversational AI | AI-Powered Application | n/a | 2024 | 2024 |
In 2024, Otsuka Pharmaceutical implemented Kore.ai for Chatbots and Conversational AI. Kore.ai is listed in vendor materials with Otsuka as a customer, confirming adoption of the Kore.ai conversational platform by the company.
The implementation concentrated on core conversational modules, including natural language understanding, intent classification, dialog management, conversation workflow orchestration, and embedded analytics to support virtual assistant workflows across web and messaging channels in line with Chatbots and Conversational AI capabilities. Governance and operational processes were put in place for conversation design, model tuning, and content lifecycle management to support iterative updates and operational control, and public materials do not disclose any specific third party system integrations.
|
Otsuka Pharmaceutical Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Audio Video and Web Conferencing | Collaboration |
|
2018 | 2018 |
|
|
|
|
|
Collaboration | Collaboration |
|
2016 | 2016 |
|
Otsuka Pharmaceutical PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2020 | 2020 |
|
Otsuka Pharmaceutical IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2016 | 2016 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2017 | 2017 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Otsuka Pharmaceutical
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Otsuka Pharmaceutical Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||